Miltefosine (impavido)
Ended Purchase Order Awarded Last action
- Contract number
- 36C26025P0684
- Awardee
-
Profounda Inc. UEI NR1ZD3ETM3N6
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $49,950
Award facts
- Opportunity
-
- 6505--Bulk Order Impavido (miltefosine) Special Notice · 36C26025P0684 · Posted Apr 22, 2025
- Contract value 100% obligated
- $49,950.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Orlando, FL 32824, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$249,750 | |
| Original award | $299,700 |
About this award
The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 20 (VISN 20) awarded a $49,950 firm fixed-price purchase order to Profounda Inc. for the supply of Impavido (miltefosine), a specialized pharmaceutical product used to treat rare and complex infections including leishmaniasis and disseminated cutaneous acanthamoeba. The contract, awarded May 1, 2025, with an ultimate completion date of October 30, 2025, represents part of a larger $1,127,000 Blanket Purchase Agreement that enables pre-positioning of this critical medication at VA medical centers. This procurement was conducted as a sole-source acquisition under the "Only One Responsible Source" authority, with no set-aside designation, reflecting Profounda's exclusive position as the sole U.S. manufacturer and licenseholder of this medication.
Profounda Inc., a self-certified small disadvantaged business headquartered in Orlando, Florida, has established itself as the VA's primary supplier for this specialized pharmaceutical intervention across multiple Veterans Integrated Service Networks. The company's registration in SAM.gov since February 2016 and consistent track record of federal contract awards exclusively with the VA demonstrate its critical role in ensuring veterans have expedited access to emergency medical solutions. The cost associated with this purchase order has been determined fair and reasonable based on historical pricing data from previous orders for the same medication.
Quick answers
Who was awarded contract 36C26025P0684?
36C26025P0684 was awarded to Profounda Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on May 1, 2025.
How much is contract 36C26025P0684 worth?
The government has obligated $49,950 on 36C26025P0684.
Was contract 36C26025P0684 competed?
The extent of competition for 36C26025P0684 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award